ARCHIVES

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | March 23, 2007

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Funding Opportunities: Lymphoma Fellowship

June 8, 2001

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process

October 10, 1997

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992